Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples